Experimental aspects of copy number variant assays at CCL3L1.
Field
Sarah F
SF
Howson
Joanna M M
JM
Maier
Lisa M
LM
Walker
Susan
S
Walker
Neil M
NM
Smyth
Deborah J
DJ
Armour
John A L
JA
Clayton
David G
DG
Todd
John A
JA
D000349:Africa / Q000453:epidemiology; D000483:Alleles; D023241:Antiretroviral Therapy, Highly Active; D001681:Biological Assay; D016022:Case-Control Studies; D019742:Chemokines, CC / Q000235:genetics*; D002886:Chromosomes, Human, Pair 17; D016000:Cluster Analysis; D015331:Cohort Studies; D004247:DNA / Q000235:genetics / Q000302:isolation & purification; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics; D018450:Disease Progression; D005006:Ethnicity / Q000235:genetics; D018628:Gene Dosage; D005787:Gene Frequency; D014644:Genetic Variation; D005838:Genotype; D015658:HIV Infections / Q000188:drug therapy / Q000235:genetics; D015497:HIV-1; D006720:Homozygote; D006801:Humans; D016133:Polymerase Chain Reaction; D044469:Racial Groups / Q000235:genetics; D012307:Risk Factors; D016019:Survival Analysis; D006113:United Kingdom / Q000453:epidemiology; D019562:Viral Load
C492767:CCL3L1 protein, human; D019742:Chemokines, CC; D004247:DNA